Fig. 2From: Protective effect of Secukinumab on severe sepsis model rats by neutralizing IL-17A to inhibit IKBα/NFκB inflammatory signal pathwayObserve the shape of abdominal organs of rats in each group with naked eyes at 24 hBack to article page